Nerve Tissue Tumors

These are tumors that start in nerve tissue. This doesn't include tumors that are located in the brain or spinal cord.

Condition

What people with Nerve Tissue Tumors report

Every report comes from a Lived member, sent anonymously.

Have you had Surgery for Nerve Tissue Tumors?

NameHow it went

About Nerve Tissue Tumors

What It Is

Nerve tissue tumors are growths made of the cells that form nerves or support them. The name describes what a tumor is built from, not just where it sits, and it covers a wide family of quite different tumors. Some are benign, meaning they are not cancer and do not spread, while others are cancers that need prompt, specialized treatment. The most common examples grow from the protective sheath that wraps nerves outside the brain and spinal cord. Schwannomas and neurofibromas are benign sheath tumors; an acoustic neuroma (vestibular schwannoma) on the nerve between the ear and brain is a well-known example. A malignant peripheral nerve sheath tumor is a rare, fast-growing cancer of the same tissue. Other members of the family grow from immature or supporting nerve cells, such as neuroblastoma, a cancer of infants and young children, and gliomas in the brain. Because these tumors behave so differently, the specific type matters far more than the umbrella name.

Causes & Risk Factors

For most nerve tissue tumors, no single cause is found. A tumor develops when changes in a cell's genes let it grow and divide more than it should, and these changes usually arise during life rather than being inherited. Inherited conditions are the clearest known risk factor. Neurofibromatosis type 1 (NF1) and the schwannomatosis conditions, including the one formerly called neurofibromatosis type 2, cause tumors to form along nerves, often many of them. They can be passed from parent to child or begin with a new gene change. NF1 also raises the lifetime chance of a malignant nerve sheath tumor, which affects roughly 8 to 13 percent of people with NF1. Some childhood neuroblastomas are linked to inherited gene changes, and radiation exposure, especially in childhood, increases the risk of meningioma, a related tumor of the brain's coverings. Having a risk factor does not mean a tumor will develop.

How It's Diagnosed

Diagnosis usually starts with symptoms or a lump, a physical and neurological exam, and imaging. MRI is the main test for showing a tumor's size, shape and relationship to the nerve; CT and PET scans can help check whether a cancer has spread. For a suspected acoustic neuroma, hearing tests are also part of the workup. Imaging can strongly suggest a tumor type, but a tissue sample (biopsy) examined by a pathologist is usually what confirms it and tells a benign tumor from a cancer. Sometimes the sample is taken during surgery to remove the tumor. When someone has several nerve tumors, or a tumor in a child, doctors may recommend genetic testing for conditions such as NF1 or an inherited form of neuroblastoma.

Treatment Options

Treatment depends on the tumor type, its location, its size and whether it is causing problems. A small, slow-growing benign tumor, such as many acoustic neuromas, may only need regular scans to check for growth. In some infants up to about six months old, neuroblastoma can shrink and disappear on its own, so close observation can take the place of surgery. When treatment is needed, surgery is the most common approach. For benign sheath tumors, removal can relieve pain or pressure, but because the tumor grows on a working nerve, surgery carries some risk to that nerve's function. Radiation is an alternative for some tumors that are hard to reach. Cancers such as malignant nerve sheath tumors and neuroblastoma usually need a team of specialists and may combine surgery, radiation, chemotherapy and, for some childhood cancers, immunotherapy or targeted drugs. For people with NF1 whose plexiform neurofibromas (large, tangled tumors along nerves) cause symptoms and cannot be fully removed, two daily pills are FDA-approved: selumetinib (Koselugo) and mirdametinib (Gomekli). They block a growth signal inside tumor cells and can shrink these tumors in a meaningful share of people (in the main childhood study of selumetinib, tumors shrank by at least a fifth in about 4 in 10 children), though they require ongoing use and regular monitoring for side effects.

What to Expect

The outlook varies enormously across this group. Many benign nerve sheath tumors grow slowly or not at all, and removing one often ends the problem, although some people have lasting numbness, weakness or hearing loss depending on which nerve was involved. Cancers such as malignant nerve sheath tumors are more serious, and survival depends heavily on the tumor's size, location and whether it has spread, which is why early care at an experienced center matters. People with NF1 or schwannomatosis usually live with the possibility of new tumors over many years. Regular checkups and scans with a specialist team help catch tumors that grow or change. Children treated for neuroblastoma need long-term follow-up, because cancer treatment can have late effects on hearing, growth and development that appear months or years later.

When to Seek Help

Arrange a medical visit for a new lump under the skin that persists or grows, hearing loss or ringing in one ear, or balance problems that persist. A child with a lump in the belly, neck or chest, or unexplained bone pain, should be seen by a doctor. If you already have a known nerve tumor or NF1, contact your care team promptly if a lump starts to grow, becomes newly or increasingly painful, or causes new weakness, since these can be signs that a tumor has become cancerous.

Questions to Ask Your Doctor

  1. 1.What exact type of tumor is this, and is it benign or cancerous?
  2. 2.Does this tumor need treatment now, or is it safe to monitor it with scans, and how often?
  3. 3.What are the chances surgery or radiation affects the nerve's function, such as feeling, strength or hearing?
  4. 4.Should I or my family have genetic testing for neurofibromatosis or another inherited condition?
  5. 5.Would it help to be seen at a center that specializes in this type of tumor?

Last reviewed • Oct 2026

Educational content, not medical advice.